Hong Kong's Fullshare says critical research report 'misleading'

HONG KONG, May 2 (Reuters) - Hong Kong property and

healthcare group Fullshare Holdings Ltd said on

Tuesday allegations by Glaucus Research that caused its shares

to plunge last week were "misleading and groundless".

California-based Glaucus Research Group, in a report last

week, queried Fullshare's stock trading patterns, its valuation

and asset disposals.

Saying the report comprised "irresponsible speculations,"

Fullshare said in a filing to the Hong Kong exchange that the

company was consulting its legal advisers and would consider

taking legal actions against Glaucus.

Glaucus, whose website does not have a phone number, did not

immediately respond to an email from Reuters seeking comment.

Fullshare said it would consider a share repurchase and

other measures to protect shareholders' interests.

Glaucus's report, the latest from an independent researcher

questioning corporate practices at a Chinese company, triggered

a trading suspension in Fullshare shares on April 25. The

company has requested a resumption on May 4.

(Reporting by Meg Shen; Editing by Mark Potter)